Product Images Donepezil Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Donepezil Hydrochloride NDC 71335-0900 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Structural Formula - 41d7651e b91a 4118 8719 bf2f663d82a2 01
Figure 1 - 41d7651e b91a 4118 8719 bf2f663d82a2 02
This text appears to be a table of ADAS-cog change from baseline for different drug treatments and a placebo. The mean change score, clinical improvement, and weeks of drug treatment are included in the table. The text is not readable because it contains several errors and missing information.*
Figure 2 - 41d7651e b91a 4118 8719 bf2f663d82a2 03
This data appears to be a graph showing the cumulative percentage of patents for different medications, as well as a chart displaying the change in ADAS-cog scores for different treatment groups and a placebo group. The graph also includes changes from baseline for a medication called Donepezil hydrochloride at 10 mg/day and 5 mg/day.*
Figure 3 - 41d7651e b91a 4118 8719 bf2f663d82a2 04
This appears to be a chart showing the percentage of patients who showed improvement or worsening in their condition after treatment with two different doses of Donepezil hydrochloride and a placebo, as measured by the CIBIC-plus rating scale. However, due to the unclear and incomplete nature of the text obtained by , it is difficult to provide a more specific description.*
Figure 4 - 41d7651e b91a 4118 8719 bf2f663d82a2 05
This appears to be a table showing the ADAS-cog change from baseline in weeks of drug treatment. The drugs being compared are Donepezil hydrochloride at two different doses and a placebo. There is no information on the extent of clinical improvement seen.*
Figure 5 - 41d7651e b91a 4118 8719 bf2f663d82a2 06
Figure 6 - 41d7651e b91a 4118 8719 bf2f663d82a2 07
This is a table showing the percentage of patients taking either 10mg/day or 5mg/day of Aricept versus placebo and their corresponding ratings on the CIBIC-plus scale for improvement or worsening. The ratings are labeled as Markedly Improved, Moderately Improved, Minimally Improved, No Change, Minimally Worse, Moderately Worse, and Markedly Worse.*
Figure 7 - 41d7651e b91a 4118 8719 bf2f663d82a2 08
Figure 8 - 41d7651e b91a 4118 8719 bf2f663d82a2 09
This is a medical prescription of Donepezil Hydrochloride at a dosage of 10 mg/day. The text also includes the term "Piacebo" and some numerical symbols that are not readable. There is also a chart labeled "SIB Change from Baseline".*
Figure 9 - 41d7651e b91a 4118 8719 bf2f663d82a2 10
Figure 10 - 41d7651e b91a 4118 8719 bf2f663d82a2 11
Label Image - lbl713350900
This is a description of a medication called Donepezil HCI, which is available in a yellow round tablet with the imprint code "HH210". The medication comes in a 10mg dose and is used to treat Alzheimer's disease. The medication should be stored at room temperature between 20°C-25°C (68°F-77°F). It is manufactured by Zhejiang Huahai Pharmaceutical Co. and is available in a package containing 30 tablets. The package has an NDC number of 7133509001 05219301523487 and an expiration date MM/YY.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.